Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Predrag Sikiric

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis FunctionPredrag Sikiric, Slaven Gojkovic, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in ArrhythmiasPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in RatsMarijan Tepes, Ivan Krezic, Hrvoje Vranes, et al.
Biomedicines|December 23, 2022
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart MuscleMario Staresinic, Mladen Japjec, Hrvoje Vranes, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related TherapeuticsPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Biomedicines|October 23, 2021
Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157Slaven Gojkovic, Ivan Krezic, Hrvoje Vranes, et al.
Biomedicines|August 6, 2021
Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157Mario Knezevic, Slaven Gojkovic, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 TherapyIvica Premuzic Mestrovic, Ivan Maria Smoday, Luka Kalogjera, et al.
Biomedicines|November 11, 2022
Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis PresentationPredrag Sikiric, Mario Udovicic, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and PossibilitiesPredrag Sikiric, Alenka Boban Blagaic, Ivan Krezic, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis FunctionPredrag Sikiric, Slaven Gojkovic, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in ArrhythmiasPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in RatsMarijan Tepes, Ivan Krezic, Hrvoje Vranes, et al.
Biomedicines|December 23, 2022
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart MuscleMario Staresinic, Mladen Japjec, Hrvoje Vranes, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related TherapeuticsPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Biomedicines|October 23, 2021
Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157Slaven Gojkovic, Ivan Krezic, Hrvoje Vranes, et al.
Biomedicines|August 6, 2021
Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157Mario Knezevic, Slaven Gojkovic, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 TherapyIvica Premuzic Mestrovic, Ivan Maria Smoday, Luka Kalogjera, et al.
Biomedicines|November 11, 2022
Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis PresentationPredrag Sikiric, Mario Udovicic, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and PossibilitiesPredrag Sikiric, Alenka Boban Blagaic, Ivan Krezic, et al.
Pageof 12